What's your position on ?
Why are you ish?
You voted ish on Vote again
Posts appear on the My Feed page of subscribers to this ticker
Wed, Feb. 3, 11:29 AM
- Cantel Medical (CMN -0.3%) acquires the Sterility Assurance Monitoring Products division of North American Science Associates (NAMSA) for $13.5M in cash. The group, which generated $5.7M in sales last year, is comprised of a broad suite of biological and chemical indicators that are used to accurately monitor the effectiveness of sterilization processes. Cantel will fold the business into its Crosstex line in its Healthcare Disposables segment.
- The transaction should be neutral to GAAP earnings and slightly accretive to non-GAAP earnings in fiscal 2016 (year end July 31) and accretive to both afterward. The deal should close in fiscal Q3.
Sep. 14, 2015, 10:05 AM
- Cantel Medical (CMN +1.5%) acquires Medical Innovations Group Holdings Limited for $79.5M in cash. The Essex, UK-based medical devices firm markets endoscopic storage and transport systems. In the 12-month period ending June 30, its posted $28.1 in revenues and EBITDA of $7.6M.
- Cantel says the transaction will be accretive to non-GAAP EPS in FY16 (ending July 31, 2016) and accretive to GAAP EPS in FY17 and beyond.
Apr. 8, 2015, 11:59 AM
- As part of its effort to focus on its core opportunities, Cantel Medical (CMN +0.2%) divests its specialty packaging business, Saf-T-Pak, to Austell, GA-based Inmark, LLC for net after-tax proceeds of $7M. The transaction will result in a fiscal Q3 accounting loss on the sale of ~$1.3M ($0.03 in GAAP EPS). The impact on non-GAAP earnings will be neutral.
Jan. 2, 2015, 9:40 AM
- Cantel Medical (CMN +2.1%) acquires Ridgeland, MS-based Pure Water Solutions for $11.9M in cash. The company provides water purification and treatment services to commercial, laboratory and medical customers throughout the Southeastern U.S.
- The transaction will be neutral to Cantel's fiscal 2015 earnings and accretive thereafter.
Jul. 1, 2014, 1:08 PM
- Cantel Medical (CMN +3%) completes its acquisition of U.K.-based PuriCore International Ltd., a wholly-owned subsidiary of PuriCore plc. The business will be renamed Cantel Medical (U.K.) Ltd. and will be part of Cantel's Endoscopy segment.
- The 120-employee firm provides automated endoscope reprocessing services and related equipment throughout the U.K.
Cantel Medical Corp provides infection prevention and control products in the healthcare market. Its operating segments include Endoscopy, Water Purification and Filtration, Healthcare Disposables and Dialysis.
Other News & PR